March 20, 2023 — A study by Emory Healthcare reports that Konica Minolta Healthcare’s Dynamic Digital Radiography (DDR), an enhanced version of a standard X-ray system that captures motion, provides more quantitative information on shoulder motion and a g

March 20, 2023 — RayzeBio, Inc., a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today announced the completion of enrollment in the Phase 1b portion of the ACTION-1 Phase 1b/3 trial of RYZ101 in patients with SSTR+ gastroenteropancreatic neuroendocrine tumors (GEP-NETs) who have progressed on Lutetium-177 labelled somatostatin analogue therapy.

March 20, 2023 — Researchers from UNSW Sydney have developed an algorithm which produces high-resolution modeled images from lower-resolution micro X-ray computerized tomography (CT).

March 17, 2023 — A new paper published in the Journal of Medical Internet Research describes how generative models such as DALL-E 2, a novel deep learning model for text-to-image generation, could represent a promising future tool for image generation, augmentation, and manipulation in health care. Do generative models have sufficient medical domain knowledge to provide accurate and useful results?

March 16, 2023 — A supply problem with Pluvicto [177Lu-vipivotide tetraxetan; Novartis], the radiopharmaceutical used to treat metastatic prostate cancer, has led to shortages resulting in a delay of 3 months or longer for new patients, which is having a profound negative impact on patient care.

March 16, 2023 — RTsafe, a leading provider of quality assurance products and services in stereotactic radiosurgery, announces that Spain’s Fundación Instituto Valenciano de Oncología (IVO) has conducted its first simulated therapy for


March 16, 2023, marks 50 years since Paul Lauterbur published his seminal Nature paper establishing zeugmatography — now familiar to most as magnetic resonance imaging or simply MRI — as a viable way to visualize objects with a magnetic field and radiofrequency signals.


March 15, 2023 — In a study of over a million women, digital breast tomosynthesis (DBT) showed improved breast cancer screening outcomes over screening with standard digital mammography alone.

Subscribe Now